Education
About Us
Working with TipRanks
Follow Us
Martin Shkreli Profile - TheStreet.com Blogger
4 Followers
Martin Shkreli TheStreet.com
Financial Blogger
Success Rate
9 out of 13 ratings made a profit
Average Return
+2.30%
Average return per rating
Time Frame
Compare to
Copying Martin Shkreli's trades since 2011 and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of 2.3% per rating.
Stock Rating Distribution
92.31% Bearish
7.69% Bullish
0.00% Neutral
Distribution of Martin Shkreli's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
US Market
US MarketBest Rating
Stock:
Horizon Therapeutics
(HZNP)
(HZNP)
Rating:Sell
Date:Jul 26, 2012 - Jul 26, 2013
Return:+64.90%
The most profitable rating made by Martin Shkreli
Martin Shkreli's Stock Coverage
Rock Creek Pharmaceuticals
Jun 05, 2011
Bearish
1Ratings
+18.30%
Epirus Biopharma
Jul 06, 2011
Bearish
1Ratings
+54.20%
Cascadian Therapeutics
Jul 25, 2011
Bearish
1Ratings
+51.00%
Chelsea Therapeutics
Jul 29, 2011
Bullish
1Ratings
-78.00%
Navidea
Aug 05, 2011
Bearish
1Ratings
-67.60%
Mesoblast
Aug 18, 2011
Bearish
1Ratings
+21.50%
Avanir Pharmaceuticals
Nov 27, 2011
Bearish
2Ratings
+0.55%
Ampio Pharmaceuticals
Jan 07, 2012
Bearish
1Ratings
+7.50%
Plus Therapeutics
Mar 19, 2012
Bearish
1Ratings
+6.10%
Lineage Therap
Apr 11, 2012
Bearish
1Ratings
+8.50%
List of latest recommendations made by Martin Shkreli. Click to expand and see Martin Shkreli's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.